Diseases, Conditions, Syndromes

Mechanisms of kidney protection by gliflozins

SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The discovery of kidney benefits ...

Diseases, Conditions, Syndromes

High-value research of 2014 presented for peri-op medicine

(HealthDay)—Articles relating to perioperative cardiac medicine, perioperative β-blocker use, perioperative pulmonary medicine, venous thromboembolism prophylaxis, and perioperative medication management are included in ...

page 8 from 8